Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation

Best Pract Res Clin Haematol. 2008 Sep;21(3):579-96. doi: 10.1016/j.beha.2008.06.003.

Abstract

Recovery of a fully functional immune system is a slow and often incomplete process following allogeneic stem cell transplantation. While innate immunity reconstitutes quickly, adaptive B- and especially T-cell lymphopoeisis may be compromised for years following transplantation. In large part, these immune system deficits are due to the decrease, or even absence, of thymopoiesis following transplantation. Thereby, T-cell reconstitution initially relies upon expansion of mature donor T cells; a proliferation driven by high cytokine levels and the presence of allo-reactive antigens. This peripheral mechanism of T-cell generation may have important clinical consequences. By expanding tumouricidal T cells, it may provide a venue to enhance T-cellular immunotherapy following transplantation. Alternatively, decreased thymic function may impair long-term anti-tumour immunity and increase the likelihood of graft-versus-host disease.

Publication types

  • Review

MeSH terms

  • B-Lymphocytes / immunology
  • Bone Marrow Transplantation
  • Dendritic Cells / immunology
  • Graft vs Host Disease / immunology*
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Immunity, Innate
  • Immunotherapy
  • Killer Cells, Natural / immunology
  • Leukemia / immunology
  • Leukemia / therapy*
  • Neoplasms / immunology
  • Neoplasms / therapy
  • Neutrophils / immunology
  • T-Lymphocytes / immunology*
  • Transplantation Conditioning